HCPCS G9077
Oncology; disease status; prostate cancer, limited to adenocarcinoma as predominant cell type; t1-t2c and gleason 2-7 and psa < or equal to 20 at diagnosis with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
Current code0 hospitals with prices
What Washington hospitals publish for this code
No Washington hospital publishes a dollar price for this code yet.
Medicare (traditional) reference
CMS publishes no national amount for this code.